Subsequent testing with CT-179 alone or in combination with radiation showed increased percentages of cleaved caspase-3-positive cells and decreased Ki67-positive cells providing evidence of efficacy in a relevant model-based system of patient-derived MB tumor. The gene discussed is CASP3; the disease is neoplasm.